Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05099276 · ClinicalTrials.gov registry record · Phase 4

Extended Postoperative Oral Tranexamic Acid in Knee Replacement

A Phase 4 study of Pain, Postoperative and Knee Osteoarthritis, sponsored by Campbell Clinic.

Active
Registry status
Phase 4
Development phase
46
Enrollment target
1
Study location

NCT05099276 is a Phase 4 study of Pain, Postoperative and Knee Osteoarthritis that is active but no longer recruiting, run by Campbell Clinic. The registered enrollment target is 46 participants, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05099276, a Phase 4 study of Pain, Postoperative and Knee Osteoarthritis, is active but no longer recruiting, sponsored by Campbell Clinic.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
46 participants
Enrollment target
1
Study location

Study Summary

A comparison of outcomes between use of oral tranexamic acid as compared to oral placebo in the first days after total knee replacement will be made to determine impact on clinical indications and patient reported outcomes.

Interventions

  • DRUG Placebo
  • DRUG Tranexamic Acid Pill

Study Locations (1)

Tennessee

  • Campbell Clinic - Germantown

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2021-12-07
Est. Completion 2024-06-01
Phase Phase 4

Sponsor

Campbell Clinic

4 total trials

What the Registry Record Tells You About NCT05099276

The ClinicalTrials.gov registry entry for NCT05099276 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (83% lower). The listed sponsor is Campbell Clinic, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05099276 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT05099276 about?

NCT05099276 is a clinical study titled "Extended Postoperative Oral Tranexamic Acid in Knee Replacement". A comparison of outcomes between use of oral tranexamic acid as compared to oral placebo in the first days after total knee replacement will be made to determine impact on clinical indications and patient reported outcomes.

What is the current status of trial NCT05099276?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2021-12-07. Estimated completion is 2024-06-01.

What conditions does trial NCT05099276 study?

This clinical trial studies the following conditions: Pain, Postoperative, Knee Osteoarthritis, Blood Loss.

What interventions are being tested in trial NCT05099276?

The interventions under investigation include: Placebo (DRUG), Tranexamic Acid Pill (DRUG).

Who is sponsoring clinical trial NCT05099276?

This trial is sponsored by Campbell Clinic, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05099276 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.